BPTH Bio-Path Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BPTH

Price (delayed)

$2.5

Market cap

$1.7M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$33.63

Enterprise value

$757,988

Bio-Path is a biotechnology company developing DNAbilize®, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous infusion. Bio-Path's lead ...

Highlights
Bio-Path Holdings's debt has decreased by 49% YoY and by 20% QoQ
Bio-Path Holdings's EPS has increased by 17% from the previous quarter and by 12% YoY
BPTH's net income is down by 16% year-on-year but it is up by 3.6% since the previous quarter
BPTH's equity has dropped by 97% year-on-year and by 83% since the previous quarter
The quick ratio has plunged by 91% YoY and by 68% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.biopathholdings.com
Peers: BAX BMY

Key stats

What are the main financial stats of BPTH
Market
Shares outstanding
678,795
Market cap
$1.7M
Enterprise value
$757,988
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.5
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$16.08M
EBITDA
-$15.9M
Free cash flow
-$11.54M
Per share
EPS
-$33.63
Free cash flow per share
-$24.13
Book value per share
$0.71
Revenue per share
$0
TBVPS
$6.74
Balance sheet
Total assets
$3.22M
Total liabilities
$2.78M
Debt
$113,000
Equity
$441,000
Working capital
$1.14M
Liquidity
Debt to equity
0.26
Current ratio
1.6
Quick ratio
0.55
Net debt/EBITDA
0.06
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-248.6%
Return on equity
-375.7%
Return on invested capital
-1,019.9%
Return on capital employed
-1,223.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BPTH stock price

How has the Bio-Path Holdings stock price performed over time
Intraday
-7.06%
1 week
-22.84%
1 month
-42.59%
1 year
81.16%
YTD
439.96%
QTD
-39.32%

Financial performance

How have Bio-Path Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$15.84M
Net income
-$16.08M
Gross margin
N/A
Net margin
N/A
BPTH's net income is down by 16% year-on-year but it is up by 3.6% since the previous quarter
The operating income is down by 14% year-on-year but it is up by 6% since the previous quarter

Growth

What is Bio-Path Holdings's growth rate over time

Valuation

What is Bio-Path Holdings stock price valuation
P/E
N/A
P/B
3.5
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Bio-Path Holdings's EPS has increased by 17% from the previous quarter and by 12% YoY
BPTH's equity has dropped by 97% year-on-year and by 83% since the previous quarter
The stock's price to book (P/B) is 75% more than its 5-year quarterly average of 2.0 but 26% less than its last 4 quarters average of 4.7

Efficiency

How efficient is Bio-Path Holdings business performance
BPTH's ROIC has shrunk by 112% YoY and by 54% QoQ
The return on equity has dropped by 74% since the previous quarter
BPTH's return on assets is down by 44% since the previous quarter

Dividends

What is BPTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BPTH.

Financial health

How did Bio-Path Holdings financials performed over time
The total assets is 16% more than the total liabilities
The quick ratio has plunged by 91% YoY and by 68% from the previous quarter
The company's current ratio has shrunk by 83% YoY and by 55% QoQ
Bio-Path Holdings's debt is 74% lower than its equity
BPTH's equity has dropped by 97% year-on-year and by 83% since the previous quarter
Bio-Path Holdings's debt has decreased by 49% YoY and by 20% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.